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tem cells are believed to regulate normal prostatic
homeostasis and to play a role in the etiology of prostate
cancer and benign prostatic hyperplasia. We show
here that the proximal region of mouse prostatic ducts is
enriched in a subpopulation of epithelial cells that exhibit
three important attributes of epithelial stem cells: they are
slow cycling, possess a high in vitro proliferative potential,
and can reconstitute highly branched glandular ductal
S
 
structures in collagen gels. We propose a model of prostatic
homeostasis in which mouse prostatic epithelial stem cells
are concentrated in the proximal region of prostatic ducts
while the transit-amplifying cells occupy the distal region
of the ducts. This model can account for many biological
differences between cells of the proximal and distal regions,
and has implications for prostatic disease formation.
 
Introduction
 
The prostate is an androgen-dependent organ that under-
goes involution after castration in experimental animals but
can completely regenerate if androgen is resupplied. Because
this involution–regeneration cycle can be repeated over 30
times, a population of long-lived, prostatic epithelial stem
cells that can survive the involution and is responsible for the
regeneration of the gland must exist (Isaacs, 1985). The iden-
tification and characterization of such stem cells is important,
because they may represent a major target of carcinogenesis
as well as a potential source of benign prostatic hyperplasia
(BPH)* (De Marzo et al., 1998; Reya et al., 2001). An under-
standing of prostatic epithelial biology is also important
because the evolution of androgen-independent prostate
carcinoma, which happens frequently as the tumor pro-
gresses, may reflect a stem cell–like state of the tumor (Reya
et al., 2001). Moreover, a better understanding of the
location and properties of prostatic stem cells may help explain
some puzzling features of the gland. For example, in the
human prostate, which can be divided anatomically into the
central, transition, and peripheral zones, carcinoma arises
mainly in the peripheral zone, whereas BPH develops largely
in the transition zone (McNeal et al., 1988; De Marzo et al.,
1998). Similar differences in disease patterns exist in the rodent
prostates, which consist of the dorsolateral and ventral prostates.
In this case, chemically induced carcinomas occur mainly
in the dorsolateral prostate (Bosland and Prinsen, 1990;
Hoover et al., 1990; Shirai et al., 1991). Whether these differ-
ences reflect the distribution of stem cells is currently unknown.
Although the overall organization of the rodent prostate
differs from that of the human gland, the rodent prostate
provides unique opportunities to study many important
features of the prostate, including the involution–regeneration
process as well as chemical and hormonal carcinogenesis. Each
murine prostatic duct consists of a proximal region attached to
the urethra, an intermediate region, and a distal tip (Sugimura
et al., 1986a; Cunha et al., 1987; Lee et al., 1990; Hayashi et
al., 1991). Proliferating cells are located at the tips of the ducts
(Sugimura et al., 1986c; Cunha et al., 1987). Based on this
finding, it has been suggested that prostatic stem cells reside in
the distal region (Kinbara et al., 1996). However, studies on
the stem cells of several other systems have indicated that the
rapidly cycling cells are most likely the so-called transit-
amplifying cells rather than stem cells. The location of prostatic
epithelial stem cells is therefore currently unknown.
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A particularly powerful method for identifying epithelial
stem cells takes advantage of the slow-cycling nature of such
cells (Berardi et al., 1995; Thorgeirsson, 1996; Beauchamp et
al., 2000; Lavker and Sun, 2000; Slack, 2000). In this proce-
dure, a tissue is long-term labeled with 
 
3
 
H-thymidine or BrdU
so that all cells, including the stem cells, are labeled. This is
followed by a “chase” period during which the label is diluted
out from all the rapidly dividing (transit amplifying) cells but
is retained by the slow-cycling (stem) cells, which can thus be
identified as the “label-retaining cells” (Cotsarelis et al., 1989;
Tani et al., 2000; Taylor et al., 2000). Using this approach,
corneal epithelial stem cells have been shown to reside in the
peripheral cornea in the limbal region (Schermer et al., 1986;
Cotsarelis et al., 1989) and this region has been used in limbal
stem cell transplantation studies to reconstitute the corneal
epithelium (Tsubota et al., 1999; Tsai et al., 2000). Using the
same label-retaining cell approach, hair follicular epithelial
stem cells have been shown to reside in the upper follicle in an
area called the bulge (Cotsarelis et al., 1990; Morris and Pot-
ten, 1999; Lavker and Sun, 2000; Taylor et al., 2000; Oshima
et al., 2001). Another important feature of stem cells is their
high proliferative potential as reflected by their ability to yield
large colonies in vitro (Barrandon and Green, 1987; Ogawa,
1993), as was shown to be the case for both the limbal zone of
the corneal epithelium (Pellegrini et al., 1999) and the bulge
area of the hair follicle (Oshima et al., 2001).
We describe here the identification of a subpopulation of
mouse prostate epithelial cells, located in the proximal region
of prostatic ducts, that are slow cycling and exhibit a high in
vitro proliferative potential. Moreover, they are able to recon-
stitute complex glandular structures in collagen gels. These
findings strongly suggest that these proximal cells are the stem
cells. Cells located at the distal tips of prostatic ducts are rap-
idly proliferating, thus representing the transit-amplifying
cells. Based on these findings, we propose a model in which
the prostatic epithelial stem cells, which are maintained in a
dormant state in the proximal region of prostatic ducts, give
rise to the proliferating transit-amplifying cells that migrate
distally to either maintain the normal prostate gland or repop-
ulate the gland during androgen-induced regeneration.
 
Results
 
Localization of slow-cycling cells in the proximal 
region of prostatic ducts
 
To localize the stem cells of mouse prostate, we performed a se-
ries of cell kinetic experiments to identify the slow-cycling cells
 
Figure 1.
 
The proximal region of mouse prostatic ducts contains a 
high density of slow-cycling stem cells.
 
 (a) Schematic diagrams 
showing the ventral and dorsal views of the urogenital organs of a 
male mouse. Ag, ampullary gland; Cg, coagulating gland; DP, dorsal 
prostate; LP, lateral prostate; Sv, seminal vesicle; U, ureter; Ub, urinary 
bladder; Ur, urethra; V, vas deferens; VP, ventral prostate. (b) A 
segment from a microdissected mouse ventral prostate illustrating 
the distal, intermediate, and proximal regions of prostatic ducts. 
Bar, 1 mm. (c) A paraffin section of a prostatic duct showing basal 
cells (arrows) immunohistochemically stained using an antibody 
against K14 keratin. Bar, 125 
 
 
 
m. (d) A paraffin section of a prostatic 
duct showing luminal cells (arrows) immunohistochemically stained 
using an antibody against K8 keratin. SMC, smooth muscle cells. 
Bar, 125 
 
 
 
m. (e) A schematic diagram illustrating the BrdU labeling 
protocol used for the identification of the slow-cycling label-retaining 
cells. In this protocol, almost all prostatic epithelial cells are initially 
labeled with BrdU. The BrdU label of the more rapidly proliferating 
transit-amplifying cells is then diluted out during the subsequent 
involution–regeneration cycles so that the label is retained only by 
the slow-cycling stem cells that can thus be identified as the 
label-retaining cells. A, testosterone pellet; Cast, castrate; I, involute; 
R, regenerate. Each cycle comprised 10 d of regeneration and 7 d of 
involution. (f) A paraffin section of a prostatic duct indicating that 
almost all epithelial cells are BrdU labeled (black cells) after the 
labeling procedure depicted in Fig. 1 e. Bar, 50 
 
 
 
m. (g) A paraffin 
section of the proximal region of a prostatic duct from the dorsal 
prostate of a mouse that had been BrdU labeled as described in 
panel e, followed by androgen withdrawal to involute the prostate. 
40 h after a pulse of androgen, animals were given 
 
3
 
H-thymidine 
and were killed 1 h later. Note that two of the red BrdU-labeled 
cells (arrow head) contain silver grains (arrows) due to 
 
3
 
H-thymidine 
incorporation, indicating that slow-cycling cells can divide after 
androgen administration. Bar, 150 
 
 
 
m. (h) A paraffin section of the 
proximal region of a prostatic duct from the ventral prostate after 11 
cycles of involution–regeneration. Note the high concentration of 
label-retaining cells in this region. Bar, 50 
 
 
 
m. (i) A paraffin section 
of the distal region of a prostatic duct from the ventral prostate after 
11 cycles. Note the small number of label-retaining cells in this region. 
Arrowheads, labeled basal cells; arrows, labeled luminal cells. 
Lu, lumen of duct. Bar, 50 
 
 
 
m. (j) A paraffin section of the proximal 
region of prostatic ducts from the dorsal prostate after 11 cycles. 
Note the high concentration of label-retaining cells in this region. 
Bar, 50 
 
 
 
m. (k) A paraffin section of the distal region of prostatic 
ducts from the dorsal prostate after 11 cycles. Note the low number 
of label-retaining cells. Bar, 50 
 
 
 
m. 
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as the label-retaining cells. The mouse prostate can be divided
into ventral (VP) and dorsolateral prostates, which can be fur-
ther divided into the lateral (LP) and dorsal (DP) lobes (Fig. 1
a). These glands can be dissected to allow the visualization of
individual ducts (Fig. 1 b), which consist of a small proximal
region (adjacent to the urethra), an intermediate region that
comprises the bulk of the duct, and a small distal region (Su-
gimura et al., 1986a; Cunha et al., 1987; Lee et al., 1990; Kin-
bara and Cunha, 1996). Previous studies have established that
these three regions, although all containing basal epithelial cells
(expressing K5/K14 keratins; Fig. 1 c) and luminal secretory
cells (K8/K18; Fig. 1 d), are morphologically and kinetically
distinct (Sugimura et al., 1986c; Rouleau et al., 1990; Hayashi
et al., 1991; Sensibar et al., 1991; Nemeth and Lee, 1996). To
label the entire population of prostatic epithelial cells, we cas-
trated a group of 3-wk-old male mice to induce prostatic invo-
lution, followed 2 wk later by androgen replacement (by the
subcutaneous implantation of testosterone pellets) to induce
prostatic regeneration (Fig. 1 e). During androgen replace-
ment, BrdU was administered continuously via a subcutane-
ously implanted osmotic pump. This resulted in the labeling of
97.5–99.8% of all prostatic epithelial cells (Fig. 1 f). To
“chase” or deplete the label from the more rapidly proliferating
transit-amplifying cells, we removed the androgen pellets to in-
duce prostatic involution, followed by reimplantation of the
androgen pellets to induce regeneration (one “cycle;” Fig. 1 e).
Mice were killed after 1, 3, 4, 6, 7, 9, 11, 12, 14, and 16 cycles
(corresponding to roughly 1, 7, 8, 15, 16, 21, 27, 29, 34, and
39 wk, respectively), and their prostates were examined histo-
logically to identify the BrdU label–retaining cells. Our results
indicate that the percentage of label-retaining cells in the dorsal
prostate declined progressively over the course of 39 wk with
repeated cycles of involution–regeneration, from almost 100 to
1% in the case of luminal cells located in the distal region (Fig.
2). Interestingly, we found that the highest number of label-
retaining cells was located in the proximal region (Fig. 1 j and
Fig. 2), with few located in the distal region (Fig. 1 k and Fig.
2). Similar results were obtained for both ventral (Fig. 1, h and
i) and dorsal prostates (Fig. 1, j and k, and Fig. 2). Significantly
higher percentages of both basal and luminal label-retaining
cells were found in the proximal compared with the distal re-
gions from the 7th to the 16th cycles (
 
P
 
 
 
  
 
0.001; Fig. 2). Al-
though they divided infrequently, occasional label-retaining
cells were observed that had incorporated 
 
3
 
H-thymidine after
the administration of androgen to an involuted prostate (Fig. 1
g). This indicates that although proximal cells are quiescent, as
evidenced by their label-retaining property, they are able to
proliferate in response to hormonal stimulation.
Although it has been suggested that prostatic basal cells serve
as the progenitors for the secretory luminal cells (Bonkhoff et
al., 1994a,b; Bonkhoff and Remberger, 1996; Robinson et al.,
1998; Danielpour, 1999; Hayward et al., 1999), this concept
is controversial (English et al., 1987; Evans and Chandler,
1987a,b; van der Kwast et al., 1998). We therefore counted
the label-retaining basal and luminal cells separately (Fig. 2). In
the proximal portion of the dorsal prostate, a high proportion
(
 
 
 
25%) of both basal and luminal cells were found to retain
the BrdU label, even after a chase period of 39 wk and a total
of 16 cycles of involution–regeneration (Fig. 2). The results of
the intermediate and distal regions were strikingly different, in
that after a chase of 39 wk, the basal cell layer contained a sig-
nificant number of label-retaining cells (8% in distal region;
Fig. 2, a and b), whereas only a few luminal cells retained the
label (
 
 
 
1% in distal region; Fig. 2, c and d). Similar results
were obtained in the ventral prostate (unpublished data). Al-
though in the proximal region, 
 
 
 
25% of both basal and lumi-
nal cells retained their label, in the distal region, most of the la-
bel-retaining cells were found in the basal layer (8 vs. 
 
 
 
1% in
the luminal cell layer; Fig. 2). Similar results were obtained
from three independent experiments. These findings indicate
that the label-retaining stem cells are concentrated in the prox-
imal portion of the mouse prostate, and that both basal and lu-
minal compartments contain slow-cycling cells. They also in-
dicate that the basal cells in the intermediate and distal regions
of the ducts retain their BrdU label longer than the luminal
cells, suggesting that the transit-amplifying luminal cells repli-
cate more rapidly than the basal cells (see below).
 
Heterogeneous distribution of the label-retaining cells
 
Although few label-retaining cells are present in the intermedi-
ate and distal regions of the ducts after a chase period of 39 wk
(Fig. 2), ducts that had been chased for an intermediate period
(9–12 cycles of involution and regeneration) revealed clusters
of label-retaining cells (Fig. 3). These clustered, label-retaining
cells were frequently associated with the “ridges” of epithelial
Figure 2. Cell kinetic data showing that the proximal region of 
the mouse dorsal prostate contains the highest percentage of 
label-retaining cells. (a) Quantification of BrdU-labeled basal cells 
in the distal (D), intermediate (I), and proximal (P) regions of ducts 
examined after various periods of chase. (b) Quantification of BrdU-
labeled basal cells in the proximal (Prox) and distal (Dist) region 
after a 39-wk chase (16 cycles). *P   0.0001. (c) Quantification of 
BrdU-labeled luminal cells in the distal (D), intermediate (I), and 
proximal (P) regions of ducts after various periods of chase. 
(d) Quantification of BrdU-labeled luminal cells in the proximal 
(Prox) and distal (Dist) region after a 39-wk chase (16 cycles). 
**P   0.0001. The absence of error bars reflects an error range too 
small to be evident on the graph. 
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folds projecting into the lumen of the duct, whereas the unla-
beled cells were associated mainly with the “valleys” connect-
ing the ridges (Fig. 3 a). Even in areas that were not folded, a
similar clustering of the labeled cells was frequently noted (Fig.
3 b). Because most of these label-retaining cells eventually lost
their label at the end of a 39-wk chase (16 cycles), they proba-
bly represent young transit-amplifying cells that had not yet
divided sufficiently to dilute out the BrdU label.
 
Localization of the rapidly cycling 
transit-amplifying cells
 
To localize the rapidly proliferating transit-amplifying cells,
we administered a pulse of BrdU to 5-, 17-, and 34-wk-old
mice and killed them 24 h later. Consistent with the fact that
the prostate is undergoing growth during adolescence, 1–10%
of epithelial cells in the prostates of 5-wk-old mice were la-
beled, whereas almost no labeling was observed in adult pros-
tates (17- and 34-wk-old mice; Fig. 4). In the dorsal prostate
of 5-wk-old mice, more BrdU-incorporating cells were found
in the distal and intermediate regions of the ducts than in the
proximal region (Fig. 4), indicating that most cell proliferation
occurred in the distal region (Sugimura et al., 1986c; Cunha
 
et al., 1987). In addition, we found that there were more
DNA-synthesizing cells in the luminal compartment (Fig. 4 b)
than in the basal compartment (Fig. 4 a); similar results were
obtained with the ventral prostate (unpublished data). These
results indicate that most of the rapidly proliferating transit-
amplifying cells are located in the distal region of the ducts
and that the transit-amplifying cells of the luminal compart-
ment cycle faster than those of the basal compartment.
 
The proximal cells have a greater in vitro proliferative 
capacity than the distal cells
 
As slow-cycling stem cells have an extensive proliferative ca-
pacity (Barrandon and Green, 1987; Ogawa, 1993; Pelle-
grini et al., 1999; Oshima et al., 2001), we assessed the pro-
liferative potential of cells isolated from proximal and distal
ductal regions. Proximal cells from the dorsal prostatic ducts
formed significantly more large colonies (16.7 
 
 
 
 1.2 colo-
nies that were 
 
 
 
100 cells; Fig. 5 a) than distal cells (3.7 
 
 
 
0.3; 
 
P
 
 
 
 
 
 0.001; Fig. 5 b). Cell counting showed that the
proximal cells of the dorsal prostate generated 
 
 
 
200-fold
more cells than the distal ones (Fig. 5 c). Cells from the prox-
Figure 3. Discrete clusters of (intermediate stage) label-retaining 
cells occur in the intermediate and distal regions of the ducts. 
Paraffin sections of the ventral prostate after a 20-wk chase showing 
that clusters of label-retaining cells (a, arrowheads) are associated 
with ridges protruding into the lumen of a duct, and (b) occur along 
the ducts (between arrows). Bars, 50  m.
Figure 4. Rapidly cycling cells are located in the distal regions of 
the prostatic ducts. The percentage of BrdU-labeled basal (a) and 
luminal cells (b) in the dorsal prostate after a single pulse of BrdU. 
Distal (Dist), intermediate (Int), and proximal (Prox) regions of the 
ducts of 5-, 17-, and 34-wk-old mice.
Figure 5. The proliferative capacity of proximal 
cells is greater than that of distal cells. Cells isolated 
from the proximal (a) and distal (b) regions of the 
dorsal prostate were seeded at 4   10
3 cells/well in 
duplicate wells of eight-well chamber slides. 
Colonies were fixed and stained 5 d later. Bars, 175 
 m. Cells isolated from the proximal (P) and distal 
(D) regions of the dorsal prostate (DP) (c) were seeded 
at 2   10
3 cells/well in duplicate wells in 96-well 
plates. The total cell output from 2   10
3 cells from 
each region was determined at the end of the serial 
culture when their growth capacity was exhausted 
(see Materials and methods). *P   0.0001. 
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imal region of the ventral prostate also had a greater prolifer-
ative capacity than those from the distal region (unpublished
data). These differences in proximal/distal ratios were noted
in animals that were 5, 10, and 34 wk old. These findings
clearly indicate that cells of the proximal region have a higher
proliferative potential than those of the distal region.
 
The proximal cells form large glandular structures 
in collagen gels
 
As prostatic cells have been shown to form three-dimen-
sional acinus-like structures in collagen gels, we isolated
cells from the proximal and distal regions of the ducts and
suspended these cells in collagen gels (Elsdale and Bard,
1972; Turner et al., 1990; Ma et al., 1997). Cells from the
proximal region gave rise to numerous, large-branched
ducts (444 
 
 
 
 9) (Fig. 6, a–f) that contained both basal and
luminal cells (Fig. 6 e) and produced prostatic secretory
products (Fig. 6, j and k). Cells from the distal region
formed far fewer such structures (46 
 
 
 
 6; 
 
P
 
 
 
 
 
 0.001). In
addition, the sizes of the glandular structures derived from
the proximal cells were ninefold larger (Fig. 6 b; 
 
P
 
 
 
 
 
0.001) and contained eightfold more branch points (Fig. 6
c; 
 
P
 
 
 
 
 
 0.001) than those derived from the distal cells. Sim-
ilar results were obtained with cells from the ventral pros-
tate. Wells containing single proximal cells gave rise to
branching ductal structures containing both basal and lu-
minal cells, indicating that these structures can be obtained
from a single cell (Fig. 6 l). These results indicate that the
proximal region is enriched in cells capable of reconstitut-
ing large, branched glandular structures that can produce
prostatic secretory products.
 
Discussion
 
Prostatic stem cells are located in the 
proximal region of the ducts
 
We have shown that the proximal cells of mouse prostatic ducts
are slow cycling (Fig. 1, h and j, and Fig. 2), have a high prolif-
erative potential (Fig. 5), and give rise to large, branched glan-
dular structures that produce prostatic secretory products (Fig.
6). These data strongly suggest that prostatic epithelial stem
cells are concentrated in the proximal region of the ducts of in-
tact animals. The proximal stem cell location is consistent with
the fact that the proximal region is least affected by castration
(Sugimura et al., 1986b; Lee et al., 1990, 1999; Rouleau et al.,
1990). In addition, the proximal region of the ducts has the
highest level of telomerase (Banerjee et al., 1998), which is asso-
ciated with the germinative compartments of many self-renew-
ing tissues (Kim et al., 1994; Wright et al., 1996). It has also
been shown that telomerase activity increases in rat prostate af-
ter castration (Meeker et al., 1996); this can be explained by the
selective loss of the nonstem cells. Taken together, these results
strongly support the idea that the prostatic epithelial stem cells
are concentrated in the proximal region of the ducts.
Our data indicate that the distal region of the intact gland
contains a population of actively proliferating cells (Fig. 4; also
see Sugimura et al., 1986c; Cunha et al., 1987). The distal tips
of the dorsal and lateral rat prostates undergo significant
growth when combined with embryonic urogenital sinus mes-
enchyme and implanted under the renal capsule (Kinbara et
al., 1996). These findings were interpreted to mean that the
distal region of prostatic ducts contains the stem cells. How-
ever, because the implant studies did not include tissues from
the proximal region for comparison, one cannot exclude the
Figure 6. Proximal cells form large, branched 
glandular structures in collagen gels. Proximal 
(Prox) and distal (Dist) cells (8   10
3 cells) from the 
dorsal prostate as well as cells from the entire dorsal 
prostate (Tot) were seeded in collagen gels and 
cultured for 6 d. The numbers of ductal structures 
(a), surface area of structures (b), and branch 
points/structure (c) in each population were 
measured. (d and g) Phase contrast microscopy 
showing the morphology of ductal structures from 
the proximal (d) and distal (g) regions of ducts. 
Bars, 150  m. (e and h) Paraffin sections of proximal 
(e) and distal (h) ductal structures showing 
immunofluorescence of basal (PE, red fluorescence) 
and luminal (FITC, green fluorescence) cells 
stained using antibodies against K14 (basal) and K8 
(luminal) keratins. Bars, 150  m. (f and i) Paraffin 
sections of proximal (f) and distal (i) ductal structures 
stained with hematoxylin and eosin. Bars, 150  m. 
(j and k) Paraffin sections of proximal ducts immuno-
histochemically stained with antibodies specific for 
prostatic secretory products (j, brown stain). Control 
(k) section stained with nonspecific antibodies. 
Sections were counterstained with hematoxylin. 
Bars, 50  m. (l) Paraffin section of a branched ductal 
structure obtained from a single proximal cell 
stained with antibodies against K14 (basal) and K8 
(luminal) keratins showing that it is comprised of 
both basal (PE, red immunofluorescence) and 
luminal (FITC, green immunofluorescence) cells. 
An asterisk indicates the lumen. Bar, 150  m. 
1262 The Journal of Cell Biology 
 
|
 
 
 
Volume 157, Number 7, 2002
 
possibility that under identical experimental conditions, cells
from the proximal region may grow even better than the distal
cells (compare Figs. 5 and 6). The observed growth of the dis-
tal region may therefore be explained by the presence of some
(young) transit-amplifying cells (Fig. 3; also see below). There
are many recent examples, including skin (Taylor et al., 2000;
Oshima et al., 2001), bone marrow (Williams, 1993; Berardi
et al., 1995), and liver (Fausto, 2000; Strain and Crosby,
2000), showing that a post-stem cell population of young tran-
sit-amplifying cells can undergo significant growth.
 
Clusters of young transit-amplifying cells
 
Another interesting finding we made is that some of the in-
termediate stage label-retaining cells, which eventually lose
their label, form clusters that are interspersed by groups of
nonlabeled cells (Fig. 3). A related, earlier observation is that
the castration-induced apoptotic cells were also found to
form clusters (Rauch et al., 1997). These two observations
can be explained if one assumes that the clusters of interme-
diate stage label-retaining cells (Fig. 3) represent young tran-
sit-amplifying cells that have not yet diluted out all their
BrdU label via cell division, and that such cells are more resis-
tant to the apoptotic effects of androgen depletion than the
older transit-amplifying and terminally differentiated cells.
Having groups of young transit-amplifying cells capable of
active proliferation placed strategically along the intermediate
and distal ducts may allow the gland to respond more rapidly
to signals for increased growth or regeneration without hav-
ing to recruit cells from the distant proximal stem cell region.
Such a dispersion of young transit-amplifying cells may facil-
itate prostatic gland regeneration, which occurs regularly in
some species. For example, male squirrel monkeys, wood-
chucks, and the vizcacha (a South American rodent) are known
to undergo seasonal variations in testosterone levels that are ac-
companied by pronounced changes in testicular volume (Bald-
win et al., 1985; Pasqualini et al., 1986; Fuentes et al., 1993).
Although measurements of prostatic size have not been done, it
is likely that prostatic involution occurs concomitantly with tes-
ticular regression. Thus, the prostate of these animals may un-
dergo physiological involution–regeneration and the strategi-
cally located, young, transit-amplifying cells within the ducts
may facilitate the rapid regeneration of the gland.
 
Basal and luminal cells may serve as prostatic 
epithelial progenitor cells
 
There are conflicting data on the nature of the epithelial
compartment in which prostatic stem cells are located. The
existence of a population of cells that possess markers for
both the basal (keratins K5 and K14) and luminal cells (K8
and K18) suggests that these represent an intermediate stage
between the precursor basal and the mature luminal cells
(Bonkhoff et al., 1994a; Bonkhoff and Remberger, 1996;
Robinson et al., 1998). In addition, a prostatic epithelial
basal cell line has been shown to give rise to luminal cells
both in vitro (Danielpour, 1999) and in vivo (Hayward et
al., 1999). These data suggest that basal cells are the precur-
sors of luminal cells. On the other hand, kinetic data show-
ing that luminal cells divide before basal cells after an andro-
gen pulse (Evans and Chandler, 1987a,b), and that the
luminal cells divide faster than the basal cells in individuals
 
on a long-term androgen block (van der Kwast et al., 1998)
have been interpreted to indicate that luminal cells are self-
renewing and are thus independent from the basal compart-
ment. However, the more rapid response of luminal cells to
androgens could also result from transit-amplifying luminal
cells being more responsive to androgens than basal cells.
Our data indicate that label-retaining cells are concentrated
in the proximal region of prostatic ducts and, importantly, are
present in both the basal and luminal compartments (Figs. 1
and 2). The presence of label-retaining cells in the luminal com-
partment is unexpected and raises the interesting possibility that
luminal cells are self-sustaining. On the other hand, our finding
does not exclude the possibility that basal cells can give rise to
luminal cells (see below), or that these label-retaining luminal
cells represent the youngest transit-amplifying cells, which re-
quire a longer period of chase to dilute out their label.
We have also shown that in the distal and intermediate re-
gions of the prostatic ducts, the luminal cells retain the
BrdU label for a shorter period of time than the basal cells
(Fig. 2). Because we know that the transit-amplifying lumi-
nal cells replicate more rapidly than the basal cells (Fig. 4), it
is not surprising that the BrdU label is diluted out more effi-
ciently from the luminal cells.
 
The prostatic stem cell niche and its possible 
regulation: a hypothesis
 
Stem cells are usually located in a niche where they are main-
tained in a quiescent state (Potten and Loeffler, 1990; Lavker
and Sun, 2000; Slack, 2000). Because the proximal region of
the prostatic ducts is enveloped by a thick band of smooth mus-
cle cells (Nemeth and Lee, 1996) that are known to produce a
high level of TGF-
 
 
 
 (Nemeth et al., 1997), it is possible that
this smooth muscle–produced TGF-
 
 
 
 plays a role in inhibiting
the proliferation of prostatic epithelial stem cells. Consistent
with this possibility, it has recently been shown that the expres-
sion of a dominant-negative form of the TGF-
 
 
 
 receptor in the
prostate induced an excessive proliferation of the prostatic epi-
thelial cells in the proximal region (Kundu et al., 2000). More-
over, there is a gradient of TGF-
 
 
 
 expression in the stroma
along the ductal axis; it is highest in the stroma surrounding the
proximal epithelium and lowest in the distal region, which is
the site of cell proliferation (Nemeth et al., 1997). A similar in-
hibitory role of TGF-
 
 
 
 is known to be responsible for main-
taining hematopoietic stem cells in a quiescent state (Cashman
et al., 1990; Hatzfeld et al., 1991; Fortunel et al., 2000).
 
A model for prostatic epithelial stem cells
 
Based on the above considerations, we propose a model of
prostatic epithelial homeostasis in which the stem cells reside
in the proximal region of the ducts and are maintained in a
quiescent state by the high local levels of TGF-
 
 
 
 (Fig. 7).
During prostatic regeneration, either a reduced level of ac-
tive TGF-
 
 
 
 or the production of an overriding, positive sig-
nal (Fig. 7, GF) stimulates the stem cells to divide, giving
rise to a cadre of transit-amplifying cells (TA
 
1 
 
→ 
 
TA
 
2 
 
→ 
 
TA
 
3
 
. . .  etc.) that migrate distally. These transit-amplifying cells
function as an immediate source of replacement cells along
the ductal axis. Upon cell division and distal migration,
transit-amplifying cells progressively lose their proliferative
potential. During involution, the oldest transit-amplifying 
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cells are preferentially lost through apoptosis; conversely,
during regeneration, the surviving (young) transit-amplify-
ing cells, which are clustered at multiple sites along the
ducts, serve as the immediate source of cell replication, thus
rapidly supplying new cells to form a regenerated gland.
This model can account for many interesting features of the
prostate gland. (a) It explains our current findings that after a
39-wk chase and 16 cycles of involution and regeneration, the
slow-cycling (label retaining) cells (Fig. 1, h and j, and Fig. 2)
are concentrated in the proximal region. (b) It explains why
cells with a high in vitro proliferative potential (Fig. 5) and the
ability to reconstitute complex glandular structures (Fig. 6)
are preferentially located in the proximal region. (c) It can ac-
count for our observation that young transit-amplifying cells
are distributed in clusters along the prostatic ducts (Fig. 3).
(d) It is consistent with the fact that the proximal region is
least affected by castration (Sugimura et al., 1986b; Lee et al.,
1990; Rouleau et al., 1990). (e) It can account for the obser-
vation that the proximal region has the highest telomerase ac-
tivity (Banerjee et al., 1998). (f) It provides a possible func-
tional explanation for the observation that the proximal
region has the highest levels of TGF-
 
 
 
 (Nemeth et al., 1997),
and that proximal cells undergo hyperproliferation when
TGF-
 
 
 
 activity is abolished in vivo (Kundu et al., 2000).
An alternative interpretation of our results may be that the
low numbers of label-retaining cells that we observe in the
intermediate and distal regions of ducts may also represent
stem cells rather than transit-amplifying cells. These cells
would survive involution, resulting in a greater proportion
of stem cells in these regions in a regressed gland. During re-
generation, these cells may give rise to transit-amplifying
cells that migrate in two directions, namely toward the distal
as well as the proximal regions. However, our results indi-
cate that even if low numbers of stem cells are located in the
intermediate and distal regions, they are concentrated in the
proximal region in a regenerated prostate.
Our finding that prostatic stem cells are concentrated in
the proximal region of ducts will facilitate their isolation and
characterization and help to elucidate the processes involved
in prostatic homeostasis and the etiology of prostatic diseases.
As both stem cells and androgen-independent prostate cancer
cells have extensive self-renewal abilities and do not depend
on androgen for their survival, the isolation and characteriza-
tion of prostatic stem cells will be of major importance for
understanding the mechanisms that result in the generation
of androgen-independent prostatic carcinoma.
 
Materials and methods
 
Animals
 
C57Bl/6 mice were housed in a climate-controlled facility and all animal
care and procedures were performed in compliance with the New York
University institutional review board requirements.
 
Detection of quiescent, slow-cycling (label retaining) cells
 
To locate the cells in the prostatic epithelium that turned over at the slow-
est rate, we developed a method for labeling the entire epithelial compart-
ment of the prostate with BrdU (Sigma-Aldrich). This was followed by
chasing the BrdU from the cells using multiple cycles of androgen with-
drawal and replacement as depicted in Fig. 1 e. Young animals (3 wk old)
were required to ensure labeling in all prostatic epithelial cells. Mice were
castrated and 2 wk later, prostate regeneration and labeling were pro-
moted by the simultaneous subcutaneous implantation of testosterone pel-
lets (Innovative Research of America) and mini-osmotic pumps (model
2002; Alza Corp.) containing 5 mg BrdU in 0.25 ml Ringer’s solution (El-
dridge et al., 1990; Lehrer et al., 1998). After 2 wk, three mice were killed to
ascertain that 98–99% of the basal and luminal compartments of the ven-
tral and dorsal prostates were labeled with BrdU. As prostatic epithelium
turns over at a slow rate, the process of chasing out the BrdU label was
hastened by cycling. The ventral and dorsal prostates were analyzed for
BrdU-containing cells at various times up to 39 wk (16 cycles of androgen
withdrawal and supplementation) after chasing out the label.
 
Detection of rapidly cycling cells
 
To compare the location of slow-cycling cells with that of rapidly cycling
cells and to determine the turnover within the epithelial compartment in
5-wk-old mice (the age at the start of the chase) with older animals, we also
administered BrdU as a pulse and determined the incidence and location of
labeled epithelial cells within the three regions (proximal, intermediate, and
distal) of the prostatic ducts. Mice 5, 17, and 34 wk old (the start, midpoint,
and end of the long-term labeling experiment) were injected intraperito-
neally with BrdU at 50 
 
 
 
g/g body weight, killed 24 h later, and the ventral
and dorsal prostates were removed. To identify slow-cycling cells that were
stimulated to divide after an androgen pulse, we injected castrated BrdU-
labeled animals intraperitoneally with testosterone propionate (4 
 
 
 
g/g body
wt) followed 40 h later with 
 
3
 
H-thymidine (8.1  Ci/g body wt). Animals
were killed 1 h later and BrdU was detected by immunohistochemistry and
3H-thymidine by autoradiography (Lehrer et al., 1998; Taylor et al., 2000).
Tissue preparation
Animals were killed by cervical dislocation and the urogenital tract was re-
moved en block and transferred into PBS, pH 7.6. The ventral and dorsal
prostates were dissected in PBS under a dissecting microscope, using 25-
gauge needles (Sugimura et al., 1986a). The tissue was fixed in 70% ethyl
alcohol in 50 mM glycine, dehydrated, and embedded in paraffin.
Figure 7. A model of prostatic stem cell homeostasis. A schematic 
diagram showing the location of prostatic epithelial stem cells (SC) 
in the proximal region of the prostatic duct. The stem cell “niche” is 
encircled by a thick band of smooth muscle cells that express a high 
level of TGF- . It is hypothesized that TGF-  maintains the stem cells 
in a quiescent state that can be overcome by an androgen-induced 
increase in the production of growth factors (GFs). The stem cells 
give rise to young transit-amplifying cells (TA1) that in turn give rise 
to further generations of transit-amplifying cells (TA2, TA3, etc.) with 
progressively diminished proliferative potential. Young transit-
amplifying cells are positioned in clusters within the ducts where 
they are available to respond rapidly to androgen and to repopulate 
the ducts after a surge in the androgen (A) level. U, urethra.1264 The Journal of Cell Biology | Volume 157, Number 7, 2002
Immunohistochemistry
Tissue sections (3  m) were deparaffinized and endogenous peroxidase was
blocked by immersing sections in 0.3% H2O2 for 20 min. After incubation in
1.5 N HCl for 15 min at 37 C, slides were washed in 0.1 M borax buffer, pH
8.5, for 10 min followed by three washes in PBS. Nonspecific binding sites
were blocked by incubation in PBS containing 10% FCS and the slides were
then incubated with peroxidase-conjugated anti-BrdU antibody (Boehringer)
for 1 h at room temperature. The antibody binding sites were visualized using
the substrate DAB (Sigma-Aldrich). Slides were lightly counterstained with he-
matoxylin. The presence of basal and luminal cells was determined (Salm et
al., 2000a) using antibodies to basal keratins 5 and 14 (BL18 and LL001) and
luminal keratins 8 and 18 (LE41 and LE61), which were a gift of E.B. Lane
(University of Dundee, Dundee, Scotland). The presence of prostatic secretory
material was detected using specific antibodies to prostatic secretory products,
which were a gift of C. Abate-Shen (Robert Wood Johnson Medical School,
Piscataway, NJ; M. Kim, M.M. Shen, and C. Abate-Shen, personal communi-
cation), and secondary HRP-conjugated antibodies with DAB as the substrate.
Enumeration of BrdU-labeled cells
The morphology of the rodent prostatic ductal system has been well de-
scribed (Sugimura et al., 1986a, Cunha et al., 1987; Lee et al., 1990; Rouleau
et al., 1990; Hayashi et al., 1991; Sensibar et al., 1991; Kinbara and Cunha,
1996; Nemeth and Lee, 1996). It can be divided into three regions, proximal,
intermediate, and distal (Fig. 1 b). At each time point, three mice were killed
and two sections from each prostate (ventral and dorsal) were examined im-
munohistochemically for evidence of labeled basal and luminal cells within
each region. At least 1,000 luminal cells and 100–200 basal cells were
counted in the distal and intermediate regions of each section, making a total
of 6,000 luminal and 600–1,200 basal cells scored for each time point. Basal
cells are less abundant than luminal cells, so fewer basal cells could be enu-
merated. The proximal region comprises a small area and hence fewer basal
and luminal cells could be scored in this region than in the intermediate and
distal regions. At least 100–200 luminal and 20–40 basal cells were counted
in the proximal region of each section, making totals of 600–1,200 luminal
and 120–240 basal cells scored for each time point.
Statistical analyses
The percentages of the BrdU-containing cells were determined by dividing
the number of labeled cells by the total number of cells scored in each re-
gion. Each time point had three animals and two sections were scored
from each ventral and dorsal prostate. For the detection of rapidly cycling
cells in animals of different age groups, three mice were used per age
group and two sections were scored from each ventral and dorsal prostate.
The results are depicted as the means and standard deviations at each time
point and comparisons between groups were made using the t test.
Cellular proliferation
The ventral and dorsal prostates of 6-wk-old mice were removed and dis-
sected under a dissecting microscope in the presence of collagenase (type
II from Clostridium histolyticum; Sigma-Aldrich) (Sugimura et al., 1986a).
The proximal and distal regions were excised and incubated in 0.5% colla-
genase for 30 min at 37 C, followed by digestion in 0.25% trypsin (BD
Biosciences) for 5 min at 37 C. Cells were resuspended in a mixture of
basal and luminal epithelial growth media (Salm et al., 2000a,b), with con-
ditioned medium from a prostatic smooth muscle cell line, PSMC1 (Salm
et al., 2000b) (40:40:20, vol/vol/vol). Cells from both regions were seeded
at 2   10
3 cells/well in collagen-coated (Cohesion) 96-well plates. Cells
were harvested, counted, and reseeded at 2   10
3 cells/well every 4–5 d.
The total cell output from 2   10
3 cells of each region was determined at
the end of the serial culture when their growth capacity was exhausted.
The ability of cells from proximal and distal regions of ducts to form colo-
nies was determined by seeding cells at 4   10
3 cells/well in collagen-
coated eight-well chamber slides. Colonies were fixed after 5 d in 70%
ethanol and stained with hematoxylin and eosin.
Duct formation in collagen gels
Cells isolated from the proximal and distal regions of ducts were sus-
pended in collagen (Elsdale and Bard, 1972) at 8   10
3 cells/100  l type 1
collagen (BD Biosciences) in 96-well dishes. After gelation, the collagen
was overlaid with 100  l medium comprising a mixture of basal and lumi-
nal growth media (Salm et al., 2000a,b) with conditioned medium as de-
scribed above. Medium was replaced daily. The collagen gels were re-
moved after 6 d, and the numbers of ducts and branch points/duct were
scored. Collagen gels were also processed for immunohistochemistry (see
above). The area of ducts was measured using an NIH image analysis pro-
gram (http://rsb.info.nih.gov/nih-image). Clonal analysis was done by seed-
ing cells at limiting dilution in 96-well microtitre dishes and verifying mi-
croscopically those wells that contained single cells.
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